| # | Drug | Count |
|---|---|---|
| 0 | GANCICLOVIR | 21 |
| 1 | GANCICLOVIR SODIUM | 21 |
| 2 | VALGANCICLOVIR | 18 |
| 3 | VALGANCICLOVIR HYDROCHLORIDE | 18 |
| 4 | ADALIMUMAB | 14 |
| 5 | ADALIMUMAB-AATY | 14 |
| 6 | ADALIMUMAB-ADAZ | 14 |
| 7 | ADALIMUMAB-FKJP | 14 |
| 8 | ETANERCEPT | 14 |
| 9 | INFLIXIMAB | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GANCICLOVIR SODIUM | 21 | 0.0020 |
| 1 | VALGANCICLOVIR | 18 | 0.0009 |
| 2 | NEVIRAPINE | 7 | 0.0008 |
| 3 | ZIDOVUDINE | 8 | 0.0008 |
| 4 | RIFABUTIN | 2 | 0.0007 |
| 5 | TOFACITINIB CITRATE | 8 | 0.0006 |
| 6 | FOSCARNET SODIUM | 2 | 0.0005 |
| 7 | ADALIMUMAB-FKJP | 14 | 0.0003 |
| 8 | ADALIMUMAB-AATY | 14 | 0.0003 |
| 9 | VORICONAZOLE | 8 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 27 | 0.0012 |
| 1 | Rifamycin Antimycobacterial [EPC] | 2 | 0.0006 |
| 2 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 8 | 0.0003 |
| 3 | Nucleoside Analog Antiviral [EPC] | 21 | 0.0002 |
| 4 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 9 | 0.0001 |
| 5 | Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 8 | 0.0001 |
| 6 | Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 8 | 0.0001 |
| 7 | Tetracycline-class Drug [EPC] | 4 | 0.0001 |
| 8 | Azole Antifungal [EPC] | 8 | 0.0001 |
| 9 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |